Medical Cannabis and Cannabinoids
Medical Cannabis and Cannabinoids is an international, open-access, peer-reviewed journal dedicated to exploring all aspects of the medical uses of cannabis and cannabinoids, and all secondary metabolites from Cannabis sativa L. This includes:
- Basic science concerning the underlying pharmacological aspects of the cannabis plant and its compounds, mechanisms of action, the endocannabinoid system, phytocannabinoids, synthetic cannabinoids, terpenes, and flavonoids
- Pre-clinical and clinical studies on indications and use of cannabis and cannabinoids in the treatment of disease and medical conditions
- Potential hazards, harms, and concerns around the use of medicinal cannabis
- Public policy forum, including legal and regulatory considerations
- Well-controlled prospective and retrospective studies of cannabis efficacy used in medical and treatment settings
The journal accepts original research, reviews, systematic reviews, case reports, brief reports, study protocols, methods papers, and letters. Karger Publishers is interested in both data showing potential efficacy as well as negative results. The journal covers a wide range of topics, including:
- Indications (and contraindications) for the use of cannabis and cannabis-derived compounds to treat diseases and medical conditions
- Pharmacological aspects, including: drug development, drug safety, dosage, and toxicology
- Psychological and psychiatric indications and concerns
- Public health, epidemiology, and socioeconomic aspects of cannabis and cannabis products
- Ethnobotany
About this Journal
Call for Papers
Minor Cannabinoids and Terpenes in Medical Cannabis: Unlocking the Potential
Submission Deadline: September 30, 2025
For Authors
Publish your paper with us.
Affiliations
News & Highlights
Karger Image Explorer
Unlock visual excellence with Karger Image Explorer, featuring over 260,000 peer-reviewed images from our esteemed journals. Easily find high-quality visuals, obtain licensing information and request reuse permissions to achieve your goals quickly and efficiently.
Research Viewpoints
Discover highlights from the latest scientific research, interviews with leading scientists, the latest developments from Karger and across the publishing industry in our research blog.
CCORC 2025: Call for Abstracts and Session Proposals
Submission Deadline: February 19, 2025, 11:59 PM EST
The Consortium for Medical Marijuana Clinical Outcomes Research is now accepting abstracts and session proposal submissions for the fifth annual Cannabis Clinical Outcomes Research Conference (CCORC) on May 29-30, 2025.
All submissions will be peer-reviewed and top abstracts will be invited for oral presentations. All abstracts accepted by the conference will be published in Medical Cannabis and Cannabinoids.
Abstracts and posters submitted by students will be considered for awards presented on the final day of the conference. Student presenters from Consortium member universities are eligible to apply for travel support.
Please reach out to [email protected] with any questions.
IMCCB-25
Building on the success of previous Swiss cannabis congresses, IMCCB-25 aspires to bring together a diverse assembly of leading researchers, clinicians, industry professionals, and other experts and opinion leaders from around the world. The conference takes place at the University of Bern, Switzerland, February 13–14, 2025.
New Tool for Evaluating Potential Drug-Drug Interactions Based on Cannabinoids
CANNabinoid Drug Interaction Review (CANN-DIR®), developed at Penn State College of Medicine, is intended to evaluate for potential drug-drug interactions based on the cannabinoids (THC & CBD) affecting the metabolism of OTHER concomitantly prescribed medications. This tool has been developed for use by healthcare providers, patients, caregivers, and interested community members. Medical Cannabis and Cannabinoids has published a product review on this tool: Drug Interaction Review (CANN-DIR™), utilizing research published in the review Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions, appearing earlier in the journal.
Issues & Articles
Connect with Us
Recommend this Journal
Suggest this journal via social media or e-mail to your colleagues.
Suggest this journal on X (formerly Twitter) Suggest this journal on Facebook Suggest this journal on LinkedIn Suggest this journal via E-mail